Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes
Huang Tz Ou, Kai Cheng Chang, Chung Yi Li, Jin Shang Wu
研究成果: Article › 同行評審
26
引文
斯高帕斯（Scopus）